Acute inflammatory diseases such as pneumonia, or chronic fibrous diseases such as pulmonary fibrosis, pose serious health challenges that can cause great suffering. These diseases not only endanger health but can greatly affect the quality of life of individuals and their families. At such times, it is crucial to have access to advanced health solutions that can alleviate pain and speed up recovery.
Fortunately, our mesenchymal stem cells (MSCs) bring hope to those struggling with serious lung diseases. MSCs are multipurpose cells with an extraordinary ability to transform into different types of cells and help the body in the restoration of damaged tissue. This is especially important in the restoration of lungs that have been damaged due to inflammation or fibrosis.
During the COVID-19 pandemic, we have witnessed numerous cases where patients infected with the virus have experienced severe respiratory distress. Some have found themselves in such a serious condition that they needed mechanical ventilation to survive. The long-term consequences of such a disease on the lungs can be extremely harmful, but the use of stem cells has shown promising results in restoring lung tissue and reducing the need for a ventilator.
Stories of patients who have experienced dramatic improvement after treatment with stem cells after a severe battle with COVID-19 and pulmonary fibrosis are living proof of the power of this therapy. Patients who once thought they would never be able to breathe normally again are now enjoying an active life with their grandchildren.
For all those who are facing uncertainty due to the health of your lungs or the lungs of a loved one, it is important to know that solutions exist. Treatment with mesenchymal stem cells opens new doors in the world of medicine and brings hope for better treatment of lung diseases. MSCs can help in the treatment of serious lung diseases. This is a big step forward in the world of medicine and something everyone should know.
MSC are multipotent cells that can differentiate into mesodermal cell lineages, such as adipocytes, osteocytes, and chondrocytes. MSC were initially isolated from bone marrow, but it is now known that they are found in almost all tissues (e.g., adipose tissue, umbilical cord, etc.). MSC have the ability to migrate to the site of injury in the body, where they can differentiate and replace damaged cells, as well as promote tissue regeneration. Additionally, they have the capacity for paracrine signaling and cell-to-cell communication by secreting various soluble factors and extracellular vesicles. In an inflammatory environment, they act immunomodulatory on different cells of the innate and adaptive immune systems, which is one of their main properties exploited for therapeutic purposes.
They can be used for local tissue regeneration or for their systemic effects.
It is important to know that PRP treatment is not the same as our therapy. PRP treatment uses only 1 to 3 stem cells, while our therapy uses a dosed amount of 15 to 20 million stem cells.
We at GaiaCell are a biotechnology company specialized in safe and effective cell therapies in orthopedics, hematooncology, pulmonology and other therapeutic areas. Our high-tech laboratories with GMP certificate and research center guarantee the highest quality and innovation. We also offer contract development and manufacturing (CDMO), ensuring top-notch project execution.